BLISS GVS PHARMA LTD

161.3 -0.6 (-0.37%) Sell

BLISSGVS investors treading cautiously as performance is muted

16 min read

BLISS GVS PHARMA LTD performed worse than the broader market today. It lost -0.37% to close at 161.3. It's recent 5 day performance has been -0.46%, -1.87%, +1.59%, +0.18% and -1.78%.

[Themes containing BLISSGVS]

BLISSGVS is currently in a down trend. Over the last three months trading short signals has not been a profitable strategy for BLISSGVS's investors in general. However, this strategy had significantly lower risk when compared to Buy-and-Hold investing (which returned -4.1%). It is therefore better to tread with caution in the current downtrend by limiting your allocation to BLISSGVS.

Trend

BLISSGVS has been outperforming the NIFTY-50 index in recent time. Over the last 3 years and 1 month, BLISSGVS underperformed the NIFTY-50 index on 53% days.

During the last three months BLISSGVS was mostly loss making and delivered on average -0.02% per day. It's best return during this period (of +12.58%) was on Friday, 28 Dec, 2018. While it's worst loss in the same period (of -9.67%) was on Thursday, 6 Dec, 2018. There was initially a bullish trend during this period which started on 29 Oct, 2018 and went on till 2 Nov, 2018. The bullish trend returned +10.73% to investors. This was followed by a bearish trend that started on 26 Nov, 2018 and ended on 6 Dec, 2018. This bearish trend lost -26.48% of investor capital.

BLISSGVS had 5 profitable and 7 loss making months over the last year. During the last year, number of profitable months of BLISSGVS and NIFTY-50 index were the same. BLISSGVS significantly outperformed NIFTY-50 index in Aug 2018, when it returned +10.83% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. BLISSGVS had a longer winning streak of losing months than NIFTY-50 index. It went down in 3 straight months (from Sep 2018 to Nov 2018) during which period it delivered -21.5%. It is interesting to note that both BLISSGVS and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

We make a living by what we get, but we make a life by what we give.
-- Winston Churchill

BLISSGVS is becoming less volatile overall. In comparison, the NIFTY-50 index is seeing a fall in volatility. During the last three months, there was a significant surge in BLISSGVS's volatility from 31 Oct, 2018 to 7 Dec, 2018. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that BLISSGVS has significant negative skewness in it's return distribution. This indicates that BLISSGVS is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than BLISSGVS. Therefore, NIFTY-50 must receive a lower allocation than BLISSGVS in your portfolio. NIFTY-50 index usually has shorter drawdown period than BLISSGVS.

Based on your interest in BLISSGVS you may find it interesting to know that SAKSOFT, NBCC and AJMERA have all performed similar to BLISSGVS and qualify as alternative investment candidates that must be evaluated for diversification.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter